Sweiti Hussein 4
4 · enGene Holdings Inc. · Filed Oct 1, 2025
Insider Transaction Report
Form 4
Sweiti Hussein
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2025-09-30+600,000→ 600,000 totalExercise: $6.83Exp: 2035-09-30→ Common Shares (600,000 underlying)
Footnotes (1)
- [F1]Non-qualified stock option grant awarded as an inducement award outside of the Amended and Restated enGene Holdings Inc. 2023 Incentive Equity Plan in accordance with NASDAQ Listing Rule 5635(c)(4). This option vests at 25% on September 29, 2026, which is the first anniversary of the employment commencement date, with the remaining portion to vest monthly over the remaining three years, subject to the reporting person's continued service.